According to Carisma Therapeutics's latest financial reports the company's current EPS (TTM) is -$3.07. In 2021 the company made an earnings per share (EPS) of -$1.01 a decrease over its 2020 EPS that were of -$0.70.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$3.07 | |
2021 | -$1.01 | 43.86% |
2020 | -$0.70 |